Jul 202020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, NC – Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with a high unmet medical need, today announced the addition of Steven Boyd and Dr Keith Maher, M.D to its Board of Directors. Both ...

Tenax Therapeutics adds Steven Boyd and Dr Keith Maher to its Board of Directors

Tenax Therapeutics adds Steven Boyd and Dr Keith Maher to its Board of Directors

From:: Tenax Therapeutics adds Steven Boyd and Dr Keith Maher to its Board of Directors

Sorry, the comment form is closed at this time.